NeuroHealing and Coma Science Group Announce Treatment of First Patient in Clinical Trial on Promising Drug for Recovery of Consciousness

Waban, Massachusetts, and Liège, Belgium (Dec 05, 2018) – NeuroHealingPharmaceuticals and the Coma Science Group at the GIGA-Consciousness,University of Liege announce the treatment of the first patient in theclinical trial: “Treating severe brain-injured patients withapomorphine: a behavioral and neuroimaging study. The study (ClinicalTrials.gov Identifier: NCT03623828, EudraCTIdentifier 2018-003144-23) will investigate the effects ofsubcutaneously administered apomorphine in…